Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2024
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Parcel Pick Up
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Masimo Corporation - Common Stock
(NQ:
MASI
)
169.36
+3.67 (+2.21%)
Streaming Delayed Price
Updated: 12:29 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Masimo Corporation - Common Stock
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Masimo Reports Third Quarter 2021 Financial Results
October 26, 2021
From
Masimo
Via
Business Wire
Earnings Scheduled For October 26, 2021
October 26, 2021
Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)...
Via
Benzinga
New Study Recommends the Use of Masimo PVi® to Guide Fluid Administration During Major Oncosurgery with Lung Ultrasonography
October 18, 2021
From
Masimo
Via
Business Wire
Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26
October 12, 2021
From
Masimo
Via
Business Wire
Earnings Scheduled For July 27, 2021
July 27, 2021
Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million....
Via
Benzinga
Masimo and University Hospitals Partner to Combat Nurse Burnout
October 04, 2021
From
Masimo
Via
Business Wire
New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically Ventilated Neonates
September 26, 2021
From
Masimo
Via
Business Wire
Masimo CEO Joe Kiani Appointed to President’s Council of Advisors on Science and Technology
September 22, 2021
From
Masimo
Via
Business Wire
Masimo Launches Single-patient-use rainbow® SuperSensor™
September 13, 2021
From
Masimo
Via
Business Wire
Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference
September 08, 2021
From
Masimo Corporation
Via
Business Wire
New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients
September 06, 2021
From
Masimo
Via
Business Wire
Masimo Partners with Penington Institute to Raise Awareness of Harm from Prescription Opioid Overdose
August 31, 2021
From
Masimo
Via
Business Wire
Masimo SafetyNet Alert™ Launches in Western Europe
August 30, 2021
From
Masimo
Via
Business Wire
Society for the Advancement of Patient Blood Management (SABM) Publication Recommends Continuous Hemoglobin Monitoring
August 26, 2021
From
Masimo
Via
Business Wire
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Exposures
COVID-19
New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneously Breathing Hemodialysis Patients
August 23, 2021
From
Masimo
Via
Business Wire
New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids
August 16, 2021
From
Masimo
Via
Business Wire
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
August 24, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...
Via
Benzinga
Exposures
Product Safety
Masimo (MASI) Q2 2021 Earnings Call Transcript
July 28, 2021
MASI earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Masimo: Q2 Earnings Insights
July 27, 2021
Shares of Masimo (NASDAQ:MASI) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 10.59% year over year to $...
Via
Benzinga
Masimo Reports Second Quarter 2021 Financial Results
July 27, 2021
From
Masimo
Via
Business Wire
Masimo Earnings Preview
July 26, 2021
On Tuesday, July 27, Masimo (NASDAQ:MASI) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings Per...
Via
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
July 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...
Via
Benzinga
Masimo Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment Manufacturing Partners
July 19, 2021
From
Masimo
Via
Business Wire
Masimo to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, July 27
July 13, 2021
From
Masimo
Via
Business Wire
New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to Predict Neurological Outcomes and Long-term Survival in Post-Cardiac Arrest ICU Patients
July 06, 2021
From
Masimo
Via
Business Wire
Masimo's Wearable Thermometer Scores FDA Approval For Prescription, OTC Use
June 21, 2021
Masimo (NASDAQ: MASI) has announced that Radius Tº, a wearable, wireless thermometer, has received FDA 510(k) clearance for both prescription and over-the-...
Via
Benzinga
Exposures
Product Safety
Masimo Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-Counter (OTC) Use
June 21, 2021
From
Masimo
Via
Business Wire
Inflation Fears and Stock Market News
June 20, 2021
Plus, best-selling author Daniel Kahneman shares insights from his new book, "Noise: A Flaw in Human Judgment."
Via
The Motley Fool
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.